WORCESTER, Mass., Oct. 29, 2008 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT) (http://www.generex.com), the leader in drug delivery for metabolic diseases through the inner lining of the mouth, announced today that, in addition to making three poster presentations of clinical data, it will host a satellite symposium at the 2nd World Congress on Controversies to Consensus in Diabetes, Obesity and Hypertension (www.codhy.com) being held in Barcelona, Spain October 30 - November 2, 2008.
